#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Detlef Siebert Email
Business Manager . SiSaf
How to contact Detlef Siebert
Join and see Detlef's contact info for free!Current Roles
Employees:
32Revenue:
$5MAbout
SiSaf is the first company to develop Bio-Courier® platform technology, a highly tailored approach that advances drug delivery into the age of personalized, precision medicine. Bio-Couriers leverage the unique properties of bioabsorbable elemental silicon (14Si) hybrids for non-viral, in-vivo gene-based therapies focused on autosomal dominate disorders. Unlike viral vectors and narrow focused non-viral delivery vehicles, Bio-Courier technology can load and protect high quantities of nucleic acids (siRNA, mRNA and DNA) which are delivered to the cytosol bypassing endosomal uptake and degradation. Furthermore the particles may be coated with targeting peptides for delivery to specific cell populations. Bio-Courier technology provides unsurpassed versatility, safety and efficiency that enables topical, systemic, and repeat administration. These unique attributes coupled with a scaled, cost efficient manufacturing process will permit broad access to safe and effective gene-based therapy for numerous autosomal dominant disorders, cost effectively.SiSaf Address
3 Huxley RoadGuildford, null